TB-500 (Thymosin Beta-4) is a 43 amino acid peptide sequence. In animal models, Thymosin Beta-4 has been shown to improve blood vessel growth, regulate wound healing, decrease inflammation, and reduce oxidative damage in the heart and central nervous system. Thymosin-beta-4 has a role in protection, tissue repair, regeneration and remodeling of injured or damaged tissues. It is also of active interest in anti-aging research.
Research
There are several scientific studies related to TB-500 (Thymosin Beta-4) peptides, including the following:
Thymosin Beta-4 Accelerates Wound Healing
Published in the Annals of the New York Academy of Sciences in 2004, this study investigates the role of Thymosin Beta-4 in accelerating wound healing, particularly in the cornea.
Thymosin β4: multiple functions in repair
Published in the Journal of Cellular Biochemistry in 2011, this review article discusses the various functions of Thymosin β4 in tissue repair processes.
Thymosin beta-4 is cardioprotective after myocardial infarction
Published in the Annals of the New York Academy of Sciences in 2007, this study explores the cardioprotective effects of Thymosin beta-4 after myocardial infarction.
Thymosin beta 4: a key factor in wound healing and fibrosis
Published in the BioFactors journal in 2011, this review article discusses the role of Thymosin beta 4 in wound healing and fibrosis.
Thymosin beta-4 inhibits corneal epithelial cell apoptosis after ethanol exposure in vitro
Published in the Investigative Ophthalmology & Visual Science journal in 2004, this study examines the potential of Thymosin beta-4 in inhibiting corneal epithelial cell apoptosis after ethanol exposure.
These studies provide insights into the potential therapeutic applications and mechanisms of action of TB-500 peptides in various physiological processes in animals, including wound healing, cardiac protection, and tissue repair.
Reviews
There are no reviews yet.